Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study
Titel:
Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study
Auteur:
Zhou, C. C. Bai, C. X. Guan, Z. Z. Jiang, G. L. Shi, Y. K. Wang, M. Z. Wu, Y. L. Zhang, Y. P. Zhu, Y. Z.